Safety of same-day-discharge radial percutaneous coronary intervention: A retrospective study

American Heart Journal

Volumn 146, Issue 4, 2003, Pages 699-704

  Ziakas, A A ^a,b   Klinke, B P ^a   Mildenberger, C R ^a   Fretz, D E ^a   Williams, E M B ^a   Kinloch, F R D ^a   Hilton, G J D ^a  

^a ROYAL JUBILEE HOSPITAL   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLEEDING; BLOOD VESSEL OCCLUSION; CARDIOVASCULAR PROCEDURES; CORONARY STENT; DEATH; EDEMA; FEASIBILITY STUDY; FEMALE; HEMATOMA; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; INFECTION; MAJOR CLINICAL STUDY; MALE; PARESTHESIA; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SAFETY; THORAX PAIN; THROMBOSIS;

EID: 0142025083     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(03)00258-8     Document Type: Article

References (26)

1. Slagboom T, Kiemeneij F, Laarman JG, et al. Actual outpatient PCI: results of the OUTCLAS pilot study. Cathet Cardiovasc Intervent 2001;53:204-8.
2. Knopf WD, Cohen-Bernstein C, Ryan J, et al. Outpatient PCI with someday discharge is safe and produces high patient satisfaction level. J Invasive Cardiol 1999;11:290-5.
3. Wilentz JR, Mishkel G, McDermott D, et al. Outpatient coronary stenting: femoral approach with vascular sealing. Herz 1999;24:624-33.
4. Kiemeneij F, Laarman GJ, Slagboom T, et al. Outpatient coronary stent implantation. J Am Coll Cardiol 1997;29:323-7.
5. Laarman GJ, Kiemeneij F, Van der Wieken LR, et al. A pilot study of coronary angioplasty in outpatients. Br Heart J 1994;72:12-5.
6. Kiemeneij F, Laarman GJ, Odekerken D, et al. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: the access study. J Am Coll Cardiol 1997;29:1269-75.
7. Mann T, Cubeddu G, Bowen J, et al. Stenting in acute coronary syndromes: a comparison of radial vs. femoral access sites. J Am Coll Cardiol 1998;32:572-6.
8. Mann T, Cowper PA, Peterson ED, et al. Transradial coronary stenting: comparison with femoral access closed with an arterial suture device. Cathet Cardiovasc Intervent 2000;49:150-6.
9. Detre KM, Holubkow K, Kelsy S, et al. Incidences and consequences of periprocedural occlusion: the 1985-1986 National Heart, Lung, and Blood Institute Registry. Circulation 1990;82:739-50.
10. Simpfendorfer C, Belardi J, Bellamy G, et al. Frequency, management and follow up of patients with acute coronary occlusion after percutaneous transluminal coronary angioplasty. Am J Cardiol 1987;59:267.
11. De Feyter PJ, Van de Brand M, Laarman GJ, et al. Acute coronary artery occlusion during and after percutaneous transluminal coronary angioplasty. Circulation 1991;83:927-36.
12. De Feyter PJ, De Jaegere PPT, Serruys PW. Incidence, predictors and management of acute coronary occlusion after coronary angioplasty. Am Heart J 1994;127:643-51.
13. Colombo A, Hall P, Nakamura S, et al. Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation 1995;91:1676-88.
14. Karrillon GJ, Morice MC, Beneviste E, et al. Intracoronary stent implantation without ultrasound guidance and with replacement of conventional anticoagulation by antiplatelet therapy: 30 day clinical outcome of the French Registry. Circulation 1996;94:1519-27.
15. Mousa I, Mario CD, Reimers B, et al. Subacute stent thrombosis in the era of ultrasound guided coronary stenting without anticoagulation: frequency, predictors, and clinical outcome. J Am Coll Cardiol 1997;29:6-12.
16. Bertrand ME, Legrand V, Boland J, et al. Randomized multicenter comparison of conventional anticoagulation versus antiplatelet therapy in unplanned and elective coronary stenting: the Full Anticoagulation Versus Aspirin and Ticlodipine (FANTASTIC) study. Circulation 1998;98:1507-603.
17. Mousa I, Oetgen M, Roubin G, et al. Effectiveness of clopidogrel and aspirin versus ticlodipine and aspirin in preventing stent thrombosis after coronary stent implantation. Circulation 1999;99:2364-6.
18. Cutlip D. Stent thrombosis: historical prospectives and current trends. J Thromb Thrombolysis 2000;10:89-101.
19. Cutlip D, Baim D, Kalon K, et al. Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001;103.1967-76.
20. EPIC Investigators. Use of monoclonal antibody directed against , the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. N Engl J Med 1994;330:956-61.
21. EPILOG Investigators. Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization. N Engl J Med 1997;336:1689-96.
22. EPISTENT Investigators. Randomized placebo-controlled and balloon-angioplasty-controlled trial to assess safety of coronary stenting with use of platelet glycoprotein-IIb/IIIa blockade. Lancet 1998;352:87-92.
23. PURSUIT Trial Investigators. Inhibition of platelet glycoprotein IIb/ IIIa with eptifibatide in patients with acute coronary syndromes. N Engl J Med 1998;339:436-43.
24. ESPRIT Investigators. Novel dosing regimen of eptifibatide in planned coronary stent implantation (ESPRIT): a randomized placebo controlled trial. Lancet 2000;356:2037-44.
25. RESTORE Investigators. Effect of platelet glycoprotein IIb/IIIa receptor blockade with tirofiban on adverse cardiac event in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty. Circulation 1997;96:1445-53.
26. Stone GW, Moliterno DJ, Bertrand M, et al. Impact of clinical syndrome acuity on the differential response to 2 glycoprotein IIb/IIIa inhibitors in patients undergoing coronary stenting: the TARGET Trial. Circulation. 200221;105:2347-54.